US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 8.260
  • +0.100+1.23%
Close Feb 28 16:00 ET
  • 8.350
  • +0.090+1.09%
Post 20:01 ET
1.22BMarket Cap-7.65P/E (TTM)

About Adaptive Biotechnologies Company

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Company Profile

SymbolADPT
Company NameAdaptive Biotechnologies
Listing DateJun 27, 2019
Issue Price20.00
Founded2009
CEOMr. Chad M. Robins
MarketNASDAQ
Employees709
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067
Websitehttp://www.adaptivebiotech.com

Company Executives

  • Name
  • Position
  • Salary
  • Chad M. Robins
  • Chairman of the Board and Chief Executive Officer
  • 8.90M
  • Kyle Piskel
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Harlan Robins, PhD
  • Chief Scientific Officer
  • 8.61M
  • Julie Rubinstein
  • President and Chief Operating Officer
  • 2.97M
  • Dr. Sharon Benzeno, PhD
  • Chief Commercial Officer, Immune Medicine
  • 2.88M
  • Francis Lo
  • Chief People Officer
  • --
  • Susan Bobulsky
  • Chief Commercial Officer, Minimal Residual Disease
  • --
  • Stacy L. Taylor
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Dr. Michael J. Pellini,M.D.
  • Independent Director
  • 310.00K
  • Katey Einterz Owen
  • Independent Director
  • 310.00K
  • Michelle Griffin
  • Independent Director
  • 330.00K
  • Peter M. Neupert
  • Lead Independent Director
  • 355.00K
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Independent Director
  • 325.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025